Johnson & Johnson Outperforms Stock Market

Johnson & Johnson (JNJ), a big pharma and consumer wellness stock, is more than holding its own in a down stock market. As of May 12, 2022 Johnson & Johnson is up 5% year-to-date while the S&P 500 is down 16%. J&J set an all-time high of $186 on April 5, 2022 while the S&P continued its downside.

J&J's diverse product line, solid earnings and solid cash flow are the reasons for its multiyear price upside. Since May 13, 1962 J&J has delivered an 14% annualized return with dividends reinvested. For the same period the S&P 500's annualized return was 7%.

J&J has recorded 59 years of consecutive annual dividend increases making it a Dividend King and a Dividend Aristocrat.

J&J is a core holding in my long-term buy-and-hold stock portfolio.

Posted May 13, 2022